XML 94 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Employee Benefit Plans (Tables)
12 Months Ended
Jan. 03, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Allocated Employee Stock-Based Compensation Expense
We allocated the stock-based compensation expense for our equity incentive plans and our ESPP as follows (in thousands):
 
Year Ended December 31,
 
2019
 
2018
 
2017
Research and development
$
19,374

 
$
13,115

 
$
7,569

Selling, general and administrative
37,228

 
27,511

 
16,369

Total stock-based compensation
$
56,602

 
$
40,626

 
$
23,938


Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value The weighted average grant-date fair value per share of stock options and ESPP purchases were as follows:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Stock options, including PSOs
$
8.19

 
$
9.07

 
$
11.42

ESPP
$
4.85

 
$
6.40

 
$
6.00


Schedule of Fair Value of Employee Share-Based Payments Awards Stock Option Assumptions and Weighted Average Fair Values
The grant-date fair value of stock option grants, including PSOs, and ESPP purchases was estimated using the following assumptions:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Stock options, including PSOs:
 
 
 
 
 
Risk-free interest rate
1.77
%
 
2.81
%
 
1.98
%
Dividend yield
%
 
%
 
%
Volatility
48
%
 
55
%
 
59
%
Expected life
4.3 years

 
4.4 years

 
4.5 years

ESPP:
 
 
 
 
 
Risk-free interest rate
2.16
%
 
1.93
%
 
1.09
%
Dividend yield
%
 
%
 
%
Volatility
50
%
 
53
%
 
58
%
Expected life
6 months

 
6 months

 
6 months


Schedule of Fair Value of Employee Share-Based Payments Awards ESPP Assumptions and Weighted Average Fair Values
The grant-date fair value of stock option grants, including PSOs, and ESPP purchases was estimated using the following assumptions:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Stock options, including PSOs:
 
 
 
 
 
Risk-free interest rate
1.77
%
 
2.81
%
 
1.98
%
Dividend yield
%
 
%
 
%
Volatility
48
%
 
55
%
 
59
%
Expected life
4.3 years

 
4.4 years

 
4.5 years

ESPP:
 
 
 
 
 
Risk-free interest rate
2.16
%
 
1.93
%
 
1.09
%
Dividend yield
%
 
%
 
%
Volatility
50
%
 
53
%
 
58
%
Expected life
6 months

 
6 months

 
6 months


Summary of All Stock Option Activity
Activity for stock options, including PSOs, during the year ended December 31, 2019 was as follows (in thousands, except per share amounts):
 
Shares
 
Weighted 
Average
Exercise Price
 
Weighted 
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Stock options outstanding at December 31, 2018
22,674

 
$
8.71

 
 
 
 
Granted
1,311

 
$
20.08

 
 
 
 
Exercised
(3,274
)
 
$
5.01

 
 
 
 
Forfeited
(217
)
 
$
16.89

 
 
 
 
Expired
(51
)
 
$
22.98

 
 
 
 
Stock options outstanding at December 31, 2019
20,443

 
$
9.91

 
3.2 years
 
$
169,299

Stock options exercisable at December 31, 2019
16,216

 
$
7.36

 
2.6 years
 
$
167,449


Summary of All RSU Activity Activity for RSUs, including PSUs, during the year ended December 31, 2019 was as follows (in thousands, except per share amounts):
 
Shares
 
Weighted 
Average
Grant Date
Fair Value
 
Weighted 
Average
Remaining
Contractual 
Term
 
Aggregate
Intrinsic
Value
RSUs outstanding at December 31, 2018
4,857

 
$
18.42

 
 
 
 
Awarded
5,842

 
$
19.46

 
 
 
 
Vested and released
(1,541
)
 
$
17.23

 
 
 
 
Forfeited
(357
)
 
$
18.66

 
 
 
 
RSUs outstanding at December 31, 2019
8,801

 
$
19.31

 
2.2 years
 
$
149,701